chr15-74826818-A-G

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001030005.3(CPLX3):​c.115A>G​(p.Met39Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000804 in 1,604,726 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000092 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000079 ( 0 hom. )

Consequence

CPLX3
NM_001030005.3 missense

Scores

1
8
10

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 8.81
Variant links:
Genes affected
CPLX3 (HGNC:27652): (complexin 3) Predicted to enable SNARE binding activity. Predicted to be involved in regulation of neurotransmitter secretion and synaptic vesicle exocytosis. Predicted to be located in plasma membrane and synapse. Predicted to be part of SNARE complex. Predicted to be active in photoreceptor ribbon synapse and terminal bouton. Predicted to be anchored component of presynaptic active zone membrane and anchored component of synaptic vesicle membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.1768527).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CPLX3NM_001030005.3 linkc.115A>G p.Met39Val missense_variant Exon 1 of 3 ENST00000395018.6 NP_001025176.1 Q8WVH0A0A384N6F4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CPLX3ENST00000395018.6 linkc.115A>G p.Met39Val missense_variant Exon 1 of 3 1 NM_001030005.3 ENSP00000378464.4 Q8WVH0
ENSG00000261606ENST00000488000.6 linkn.3324A>G non_coding_transcript_exon_variant Exon 12 of 14 2
ENSG00000261606ENST00000564823.1 linkn.3553A>G non_coding_transcript_exon_variant Exon 4 of 6 2

Frequencies

GnomAD3 genomes
AF:
0.0000921
AC:
14
AN:
152058
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00289
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.000479
GnomAD3 exomes
AF:
0.000158
AC:
38
AN:
240464
Hom.:
0
AF XY:
0.000176
AC XY:
23
AN XY:
130680
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000905
Gnomad ASJ exome
AF:
0.00235
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000234
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000367
Gnomad OTH exome
AF:
0.000175
GnomAD4 exome
AF:
0.0000792
AC:
115
AN:
1452668
Hom.:
0
Cov.:
31
AF XY:
0.0000996
AC XY:
72
AN XY:
722754
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000680
Gnomad4 ASJ exome
AF:
0.00251
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000210
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000208
Gnomad4 OTH exome
AF:
0.0000999
GnomAD4 genome
AF:
0.0000921
AC:
14
AN:
152058
Hom.:
0
Cov.:
32
AF XY:
0.000108
AC XY:
8
AN XY:
74274
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00289
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000294
Gnomad4 OTH
AF:
0.000479
Alfa
AF:
0.000315
Hom.:
0
Bravo
AF:
0.0000869
ExAC
AF:
0.000107
AC:
13

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Nov 17, 2022
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.115A>G (p.M39V) alteration is located in exon 1 (coding exon 1) of the CPLX3 gene. This alteration results from a A to G substitution at nucleotide position 115, causing the methionine (M) at amino acid position 39 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.51
BayesDel_addAF
Benign
-0.013
T
BayesDel_noAF
Uncertain
0.040
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Benign
0.39
T
Eigen
Uncertain
0.63
Eigen_PC
Uncertain
0.59
FATHMM_MKL
Uncertain
0.82
D
LIST_S2
Pathogenic
0.98
D
M_CAP
Benign
0.051
D
MetaRNN
Benign
0.18
T
MetaSVM
Benign
-0.29
T
MutationAssessor
Uncertain
2.7
M
PrimateAI
Uncertain
0.59
T
PROVEAN
Benign
-1.9
N
REVEL
Benign
0.27
Sift
Benign
0.054
T
Sift4G
Benign
0.10
T
Polyphen
0.84
P
Vest4
0.62
MutPred
0.41
Gain of glycosylation at S40 (P = 0.2572);
MVP
0.73
MPC
0.88
ClinPred
0.16
T
GERP RS
4.3
Varity_R
0.45
gMVP
0.59

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs761543817; hg19: chr15-75119159; COSMIC: COSV59002715; COSMIC: COSV59002715; API